9.30am - 10.00am Registration and morning coffee

10.00am - 10.15am

OFFICIAL OPENING

The growth opportunity for life sciences in Australia

Glenn Cross, Chief Executive Officer, AusBiotech

10.15am - 10.45am

KEYNOTE: Successful Australian medical technology in China

Dr David Burton, Founder, Chairman and CEO, Compumedics Limited (ASX: CMP)
- presentation not available, please contact dburton@compumedics.com.au to contact the speaker

10.45am - 11.15am

Company Spotlight Presentations

- Dr Brad Walsh, Chief Executive Officer, Minomic International
- link to presentation

- Ian Richards, Head of Marketing, Grunbiotics
- link to presentation

- Dr Ross Macdonald, Managing Director and Chief Executive Officer, Cynata Therapeutics Limited (ASX:CYP)
- link to presentation

11.15am - 11.45am Morning tea and networking opportunity

11.45am - 12.15pm

PANEL: China Deals – hot sectors for investment & partnering

Moderator: Rob Scott, Director, China BlueSky Partners

  • Mark Harrison, Deal Advisory Partner, KPMG Advisory (China) Limited
  • Jimmy Zhang, Managing Director, Cross-Border Investment, CL Investment Group
  • Russell Bateman, Chief Operating Officer, CPIC Allianz Health Insurance
  • Dr Michael Chen, Head of External Innovation China, Merck KGaA
12.15pm - 1.00pm

Company Spotlight Presentations

- John Martin, Chief Executive Officer, Regeneus (ASX:RGS)
- link to presentation

- Steven Lydeamore, Chief Financial Officer, Bionomics Limited (ASX:BNO)
- link to presentation - 
English version / Chinese version

- Assoc Professor Derek RichardCARP Pharmaceuticals
- link to presentation

Robert Proulx, Chief Executive Officer, Imagion Biosystems (ASX:IBX)
- link to presentation

1.00pm - 2.00pm

Lunch and networking opportunity

2.00pm - 2.15pm

PRESENTATION: Official Launch of AusBiotech China Member Initiative
and Australia China Life Science Partnering Program

Glenn Cross, Chief Executive Officer, AusBiotech

2.15pm - 2.45pm

PANEL: The face of life science investment in the new China

Moderator: Glenn Cross, Chief Executive Officer, AusBiotech

Panelists:

2.45pm - 3.00pm

KEYNOTE:

Max Wang, Chief Executive Officer, FirstBiotech (Australia)
- link to presentation

3.00pm - 3.30pm

Afternoon Tea and networking opportunity
Signing ceremony between Australia China Technology Incubator and Joyin Innovation & Manufacturing Center
Officiated by Tim Dillon, Consulate General of Victoria (China)

3.30pm - 4.15pm

PRESENTATION: Launch of Australia China Technology Incubator
Rob Scott
, Director, China BlueSky Partners
- link to presentation

PANEL: Incubation in China as a pathway to success

Moderator: Rob Scott, Director, China BlueSky Partners

  • Cindy Zhai, Founder / General Manager, Shanghai Zhangjiang Joyin Innovation & Manufacturing Center
  • Sebastien Gaudin, CEO & Co-founder, The CareVoice
  • Cecilia Jiang, Senior Project Manager of Fenglin Biomedical Center, BioFM
  • Daniel Zhan, Landing Pad Shanghai (Austrade)
4.15pm - 4.30pm

CLOSE - DAY ONE

Li Fern Woo, Partner Life Sciences, KPMG Shanghai

5.00pm - 7.00pm

Networking Reception

The Blind Pig

132 Nanyang Lu, Jin’an District (5 minutes walk from KPMG)

9.30am - 10.00am      Registration and morning coffee

10.00am - 10.05am

WELCOME - DAY TWO

10.05am - 10.45am

KEYNOTE: Clinical Trials in Australia

PANEL: Australia’s – Phase 1 Trial Fast Track

Moderator: Sue MacLeman, Managing Director and Chief Executive Officer, MTPConnect

Panelists from Australian trial sites:

  • Tina Soulis, Chief Executive Officer, Neuroscience Trials Australia
  • Jane Kelly, CEO, CMAX Clinical Research
  • Megan Ford, Senior Director Research & Development, IQVIA
  • Jayden Rogers, VP Global Partnering, Linear Clinical Research
  • Dr Kurt Lackovic, Chief Executive Officer, Cancer Trials Australia
  • Kevin Wightman, Executive Director, Nucleus Network Limited
10.45am - 11.15am

Company Spotlight Presentations

- Tina Soulis, Chief Executive Officer, Neuroscience Trials Australia
- link to presentation English version / Chinese version

- Jane Kelly, Chief Executive Officer, CMAX Clinical Research
- link to presentation

- Megan Ford, Senior Director Research & Development, IQVIA
- link to presentation

11.15am - 11.30am

Morning Tea and networking opportunity

11.30am - 12.15pm

Company Spotlight Presentations

- Dr Ryan Parlett, Director Business Management Pharma Services, Patheon
- link to presentation

- Jayden Rogers, VP Global Partnering, Linear Clinical Research
- link to presentation

- Dr Kurt Lackovic, Chief Executive Officer, Cancer Trials Australia
- link to presentation English version / Chinese version

- Kevin Wightman, Executive Director, Nucleus Network Limited
- link to presentation English version / Chinese version

- Angela Luttick, Executive Vice President, Business Development and Preclinical, 360biolabs
link to presentation

 

12.15pm - 12.30pm

KEYNOTE: Update on IP in China

12:30pm - 1:00pm

PANEL: Trusted Advisors in China

Moderator: Glenn Cross, Chief Executive Officer, AusBiotech

  • Hans Verheul, National Life Sciences Sector Lead, KPMG Australia
  • David Bennett, Counsellor (Intellectual Property), Australian Embassy, Beijing
  • Martyn Huckerby, International Partner, King & Wood Mallesons
  • Grace Xie, Head of Life Science Tax, KPMG Shanghai
  • Brandwood Biomedical
  • Udo Doring, CEO AustCham Shanghai
  • Dane Richmond, Trade Commissioner Austrade
  • Junhua Shang, Country Lead, Brandwood Biomedical
1:00pm - 2:00pm

Lunch and networking opportunity

OFFICIAL CLOSE